Genome-Wide Meta-Analysis for Serum Calcium Identifies Significantly Associated SNPs near the Calcium-Sensing Receptor (CASR) Gene
Kapur et al., PLoS Genetics
An international team of researchers reports its genome-wide association study of serum calcium's association with SNPs in or near the calcium-sensing receptor gene on 3q13. "This genome-wide meta-analysis shows that common CASR variants modulate serum calcium levels in the adult general population," the researchers write, adding that their "results show that CASR is a key player in genetic regulation of serum calcium in the adult general population."
Drug Safety Whistleblower Wants to Fix FDA. GTO Says, Good Luck!
July 23, 2007
The International Herald Tribune profiles Steven Nissen, the Cleveland Clinic scientist best known for his early warnings about the safety of Vioxx, long before the drug was taken off the market. Just a few months ago he sounded the alert about diabetes drug Avandia, and he is now rumored to be eyeing a post at FDA. (In an interview, Nissen recently said, "I want to fix the FDA.") According to the article, "By digging deeply into companies' own clinical trial data — information that used to be available only to U.S. drug regulators who did not always mine it as aggressively — Nissen is among a new cadre of activist scientists demanding greater vigilance on drug safety."
Which leaves us at GTO wondering, if Nissen can track this information to come up with safety warnings for these drugs, why isn't everyone doing the same thing?
